Sodium (2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-(3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14,19-trioxo-2,4,6-trioxa-18-thia-11,15-diaza-3lambda~5~,5lambda~5~-diphosphaicos-1-yl)tetrahyd ro-3-furanyl hydrogen phosphate (non-preferred name)(CAS: 102029-73-2)

The compound is a complex organic salt with a high molecular weight and crystalline form. It has a low solubility in water but higher solubility in organic solvents. Chemically, it is highly reactive, particularly with bases and nucleophiles. The compound shows strong reactivity towards nucleophilic substitution reactions and can form stable complexes with metal ions.

The compound is synthesized via a multi-step reaction involving the condensation of a purine derivative with a sugar analogue followed by a series of functional group transformations. Common catalysts include metal complexes and organocatalysts, with high selectivity and yield achieved through careful control of reaction conditions.

This compound is primarily used in the pharmaceutical industry for its potential as a drug candidate, particularly in the development of antiviral and anti-inflammatory agents. It may also find applications in the polymer and sensor industries due to its unique chemical structure and properties.

When handling this compound, it is crucial to use appropriate personal protective equipment (PPE) such as gloves, goggles, and a lab coat. It should be handled in a well-ventilated area or a fume hood to minimize exposure to the environment. Spills should be cleaned up carefully using appropriate absorbents, and the area should be thoroughly washed down. Refer to the Safety Data Sheet (SDS) for specific handling and disposal instructions.